Ligand Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Operating Revenue	684.96	808.39	682.15	676.48	499.67	329.75	Upgrade
Revenue	684.96	808.39	682.15	676.48	499.67	329.75	Upgrade
Revenue Growth (YoY)	-13.85%	18.51%	0.84%	35.39%	51.53%	-34.52%	Upgrade
Gross Profit	684.96	808.39	682.15	676.48	499.67	329.75	Upgrade
Other Operating Expenses	362.96	439.95	323.39	233.27	219.57	234.73	Upgrade
Operating Expenses	468.21	552.4	428.93	318.64	326.43	349.21	Upgrade
Operating Income	216.75	255.99	253.22	357.84	173.24	-19.46	Upgrade
Interest Expense	-15.75	-18.32	-23.01	-18.97	-14.24	-15.81	Upgrade
Interest & Investment Income	2.59	2.6	3.44	0.26	0	1.81	Upgrade
Earnings From Equity Investments	131.58	107.78	200.31	22.4	22.94	-17.57	Upgrade
Currency Exchange Gain (Loss)	-2.51	-3.53	2.72	-2.08	3.81	5.93	Upgrade
Other Non Operating Income (Expenses)	-3.05	-3.4	-2.95	-2.58	-5.85	-3.23	Upgrade
EBT Excluding Unusual Items	329.61	341.11	433.74	356.88	179.88	-48.34	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0	-	Upgrade
Gain (Loss) on Sale of Assets	-0.15	-0.03	-0.09	-1.31	-14.49	-3.05	Upgrade
Asset Writedown	-	-	-	-	-	-477.36	Upgrade
Other Unusual Items	13.37	2.16	-60.35	-4.22	-0.76	-33.64	Upgrade
Pretax Income	342.84	343.24	373.3	351.36	164.63	-562.38	Upgrade
Income Tax Expense	94.22	96.76	131.21	145.47	43.68	29.49	Upgrade
Earnings From Continuing Operations	248.62	246.48	242.09	205.89	120.96	-591.87	Upgrade
Minority Interest in Earnings	-12.73	-13.3	-31.89	-1.07	-1.22	2.89	Upgrade
Net Income	235.89	233.18	210.2	204.82	119.73	-588.98	Upgrade
Net Income to Common	235.89	233.18	210.2	204.82	119.73	-588.98	Upgrade
Net Income Growth	-8.64%	10.94%	2.63%	71.06%	-	-	Upgrade
Shares Outstanding (Basic)	199	199	199	198	197	197	Upgrade
Shares Outstanding (Diluted)	200	200	200	199	198	197	Upgrade
Shares Change (YoY)	-0.17%	-0.00%	0.43%	0.57%	0.21%	0.40%	Upgrade
EPS (Basic)	1.18	1.17	1.06	1.03	0.61	-2.99	Upgrade
EPS (Diluted)	1.18	1.17	1.05	1.03	0.61	-2.99	Upgrade
EPS Growth	-8.45%	11.43%	1.94%	69.21%	-	-	Upgrade
Free Cash Flow	95.62	131.48	163	263.38	115.83	62.79	Upgrade
Free Cash Flow Per Share	0.48	0.66	0.82	1.32	0.59	0.32	Upgrade
Dividend Per Share	0.342	0.342	0.332	0.246	0.159	-	Upgrade
Dividend Growth	3.03%	3.03%	34.90%	54.38%	-	-	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	31.64%	31.67%	37.12%	52.90%	34.67%	-5.90%	Upgrade
Profit Margin	34.44%	28.85%	30.81%	30.28%	23.96%	-178.61%	Upgrade
Free Cash Flow Margin	13.96%	16.26%	23.89%	38.93%	23.18%	19.04%	Upgrade
EBITDA	296.43	336.75	372.31	432.78	279.68	88.46	Upgrade
EBITDA Margin	43.28%	41.66%	54.58%	63.98%	55.97%	26.83%	Upgrade
D&A For EBITDA	79.68	80.76	119.08	74.94	106.44	107.92	Upgrade
EBIT	216.75	255.99	253.22	357.84	173.24	-19.46	Upgrade
EBIT Margin	31.64%	31.67%	37.12%	52.90%	34.67%	-5.90%	Upgrade
Effective Tax Rate	27.48%	28.19%	35.15%	41.40%	26.53%	-	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.